This chemical is primarily used as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its unique structure allows it to effectively induce chirality in the synthesis of complex organic molecules, making it valuable in the production of pharmaceuticals and fine chemicals. It is often employed in asymmetric hydrogenation, carbon-carbon bond formation, and other stereoselective transformations. The ligand's ability to form stable complexes with metals like rhodium, iridium, and palladium enhances catalytic efficiency and selectivity, enabling the synthesis of enantiomerically pure compounds. This is especially crucial in the development of active pharmaceutical ingredients (APIs) where specific enantiomers often exhibit desired biological activity.